Patient Perspectives on Digital Technology and Experiences of Computerized History-Taking for Chest Pain Management in the Emergency Department: CLEOS-CPDS Prospective Cohort Study

Automated, self-reported medical history-taking has the potential to provide comprehensive patient-reported data across a wide range of clinical issues. In the Clinical Expert Operating System-Chest Pain Danderyd Study (CLEOS-CPDS), medical history data were entered by patients using tablets in an e...

Full description

Saved in:
Bibliographic Details
Published inJMIR medical informatics Vol. 13; p. e65568
Main Authors Fritzell, Kaisa, Brandberg, Helge, Spaak, Jonas, Koch, Sabine, Sundberg, Carl Johan, Zakim, David, Kahan, Thomas, Sundberg, Kay
Format Journal Article
LanguageEnglish
Published Canada JMIR Publications 17.06.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Automated, self-reported medical history-taking has the potential to provide comprehensive patient-reported data across a wide range of clinical issues. In the Clinical Expert Operating System-Chest Pain Danderyd Study (CLEOS-CPDS), medical history data were entered by patients using tablets in an emergency department (ED). Since successful implementation of this technology depends on understanding patients' views and willingness to use it, we have studied these factors following patients' use of the CLEOS program. This study aimed to develop and use a questionnaire to investigate patients' attitudes, perceptions and skills related to using digital technology in health care in general, and specifically their experiences with the CLEOS program during their visit to an ED with a chief complaint of chest pain. The study included the development of a questionnaire, followed by a cross-sectional study. Questionnaire design and the technology acceptance model underpinned the development of the questionnaire. The think-aloud method was used to test the questionnaire. Adults who participated in the CLEOS-CPDS were invited consecutively to respond to the questionnaire. Descriptive and correlational analyses were performed. The refinement of the questionnaire included language revision, removal of similar items, and replacement of some response formats. The final questionnaire consisted of 16 items and one free text comment that assessed attitudes, perceptions, and skills related to the use of digital technology in health care in general and the specific experience of using self-reported history-taking by CLEOS. The majority of the 129 patients (mean age 56, SD=17.3 y) who answered the questionnaire found it easy to use digital technology in general (118/129, 91%), that digital technology has a role when seeking health care (115/129, 91%), and that patient-reported symptoms are helpful in making a diagnosis (83/129, 65%). There were some concerns that the patient-physician interaction would be disrupted when using digital technology (48/129, 38%). The overall experience of using CLEOS was positive and most felt confident in answering the questions on a tablet (118/129, 91%). Older age was associated with less ease (P<.001), confidence (P<.001), and trust (P=.002) when using digital technology, as well as less confidence in answering the questions in CLEOS (P=.019). Moreover, older age was associated with more worry about the potential disruption of the patient-physician personal contact when using digital technology (P<.001). This study suggests strong approval of usefulness and trust in digital technology among patients with chest pain visiting a cardiology ED, but the concern for lack of personal contact should be acknowledged. End users found the CLEOS program to perform well but recommend some adjustments for future studies. The questionnaire responses provided some new insights on perceived usability of digital technology for health care delivery, and it appears relevant for future evaluations of CLEOS in other contexts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
DZ is the inventor of US patents for technology related to the CLEOS program. All patent rights and copyrights to technology, language, images and knowledge content are assigned without royalty rights by DZ to Karolinska Institutet, Stockholm, Sweden, which is a public university. Only Karolinska Institutet and its subsidiaries may be owners or receive royalties or other revenue from use of CLEOS technology, language, images, knowledge content or from clinical insights and/or computer algorithms generated from analysis of data acquired by the program. HB receives speaker honoraria for AstraZeneca.
JS receives speaker honoraria from Bayer, AstraZeneca, Boehringer Ingelheim, NovoNordisk and Sanofi.
ISSN:2291-9694
2291-9694
DOI:10.2196/65568